SharpLink Gaming

Phase A — Understand the business

Lens 1 · Company Overview

What it is now. Two segments, wildly mismatched in size:

1. ETH Treasury Management — the entire reason to own the stock. SharpLink accumulates Ethereum as a permanent balance-sheet asset and stakes ~100% of it for yield. As of the latest reports it holds ~867,798–872,984 ETH (≈$1.45–1.72B at ~$1,660 ETH). This makes it the second-largest publicly traded ETH holder behind BitMine Immersion (BMNR).
2. Affiliate Marketing (legacy) — the original 1995-vintage sports-betting/iGaming affiliate business operating through the PAS.net network and a portfolio of state-specific affiliate sites, driving leads to sportsbooks (BetMGM, DraftKings, Caesars, FanDuel, Bet365, etc.) on a per-lead / per-deposit / rev-share basis. Revenue model is referral commissions. This business is in secular decline (−24% revenue, net-margin collapse by Mar 2025) and was de-emphasized after the C4 conversion-tech product was discontinued in Dec 2023 for "lack of market acceptance".

How it actually makes money. Operationally, almost not at all from operations — Q1 FY2026 revenue of $12.1M was driven by $11.5M of ETH staking rewards, not the affiliate business (which is now a rounding error). The "earnings" are dominated by mark-to-market swings on the ETH position. The real value-creation engine is growing ETH-per-share — accumulating more ETH per diluted share over time, via (a) accretive equity issuance when the stock trades above NAV, (b) staking yield compounding, and (c) buybacks when it trades below NAV.

Key payment-term structure. There is no take-or-pay or recurring-contract base. The "contract" is implicit: shareholders own a claim on a pile of staked ETH. The closest thing to recurring revenue is the staking yield (~3–4% net), which is a function of the ETH protocol, not customer contracts.

Customers / suppliers / competitors. "Customers" = passive ETH-exposure-seeking equity investors. "Suppliers" = staking infrastructure (Liquid Collective, Figment, Galaxy, increasingly in-house) and the Ethereum protocol itself. Competitors = other ETH DATs (BitMine #1), spot ETH ETFs (BlackRock's ETHA, >$10B), and simply holding ETH directly.

Lens 2 · Supply Chain

For a treasury company the "supply chain" is the capital-in → ETH-acquisition → staking → yield pipeline. Named stakeholders along it:

• Capital sources (upstream): Consensys (lead, $425M PIPE, Jun 2025); crypto-VC syndicate — Pantera Capital, ParaFi Capital, Electric Capital, Galaxy Digital; and the public market via a $6B ATM equity program + registered direct offerings (e.g. $400M at $21.76, $76.5M at a 12% premium).
• ETH acquisition (the product): open-market + OTC purchases, ~$3.1B deployed at an average cost basis of ~$3,609/ETH.
• Staking infrastructure (the yield engine): Liquid Collective and Figment institutional liquid-staking (producing LsETH); weETH (EtherFi-style restaking wrapper, "WE ETH" in filings); increasingly in-house native staking; plus a $200M deployment on Linea (Consensys' own L2) and a planned $125M Galaxy-SharpLink Onchain Yield Fund (SharpLink ~$100M / Galaxy $25M) for measured DeFi yield.
• Custody / risk: institutional custody within a "governance, custody, and risk-management framework".

Chokepoints / single-source dependencies. (1) ETH price is the master input — everything is one beta. (2) The Ethereum protocol's staking yield sets the only organic cash flow; a yield cut hits the model. (3) Slashing / smart-contract risk on liquid-staking and DeFi venues (the Q1 transcript explicitly waved off recent "DeFi exploits" as "human exploits" — a tell that this risk is live). (4) Linea concentration — deploying on Consensys' own L2 is a related-party-adjacent dependency. Names-or-it-didn't-happen: the chain is Consensys → SBET balance sheet → Liquid Collective/Figment/EtherFi/Linea/Galaxy → Ethereum validators → staking yield → compounded back into ETH.

Lens 3 · Competitive Advantages (moats)

This is where a DAT's moat is genuinely thin — and where SBET is differentiated only by people and discipline, not structure.

• No product moat. Anyone can buy and stake ETH. A spot ETH ETF (ETHA) does it with lower fees and no equity-issuance dilution. The honest base case: a DAT has negative structural moat vs. an ETF unless it can (a) issue equity accretively above NAV or (b) generate excess yield.
• The actual edge — operator quality. SBET's differentiator is the strongest management/board in the ETH-treasury category: Chairman Joseph Lubin (Ethereum co-founder, Consensys CEO) and Co-CEO Joseph Chalom (20 yrs at BlackRock; built IBIT, ETHA, and BUIDL — literally the person who shipped the largest ETH ETP). For a strategy whose only edge is "stake smarter and allocate capital rationally," this is a real, if soft, moat — it lowers cost of capital (institutions trust the syndicate) and improves yield execution ("beating the staking rate" as a stated hurdle).
• Bargaining power. Low over "suppliers" (the protocol sets yield) but improving over capital providers — the Consensys/Pantera/Galaxy syndicate and 46% institutional ownership give it cheaper, stickier capital than a no-name DAT.
• The disciplined-allocation moat (the differentiator vs. BMNR). SBET's $1.5B crypto-collateralized buyback — buy stock only when it trades below NAV ("immediately accretive" to ETH/share) — is a genuine governance edge over BitMine's "dilute relentlessly" model. A Seeking Alpha contributor framed the choice as "a $1.5B buyback over 50 billion shares of dilution." That is the closest thing to a durable moat here: capital-allocation rationality.

Lens 4 · Segments

No segments.csv in the research layer → all ``. Two reportable segments:

Geography: not meaningfully broken out; the ETH treasury is global/protocol-level, the legacy affiliate footprint is US-regulated states + Ontario. The segment story is brutally simple: one segment is becoming the company, the other is evaporating. Revenue rose from $0.7M → $12.1M YoY purely on staking. Reconciliation flag: 589,305 native ETH at Mar 31 vs. 872,984 total ETH-equivalent by May 4 — the gap is liquid-staking wrappers (LsETH/weETH) plus continued accumulation, not a 280K-ETH purchase in five weeks.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — Q1 FY2026, quarter ended Mar 31 2026)

The headline numbers look catastrophic and are economically near-meaningless — which is the single most important thing to understand about reading a DAT's P&L.

• Revenue: $12.1M vs. $0.7M YoY — a 17x jump, entirely staking.
• Net loss: $(685.6)M, LPS $(3.25) (vs. $(1.73) prior-year quarter).
• Loss bridge: $191.7M impairment on staking derivatives (marked at the lowest intraday price) + $506.7M unrealized loss on ETH, partly offset by a $12M realized gain on LsETH redemption.
• The critical caveat (CFO DeLucia, directly): "these impairment charges and unrealized losses … do not represent a realized economic loss on our ETH position nor do they reduce the number of ETH units we hold". Under current GAAP, ETH/derivatives are impaired down to lows but not marked up on recovery — so the loss overstates economic damage. A pending FASB fair-value decision could fix this asymmetry.
• Balance-sheet flags: Cash on hand just $16.9M (down from $28.5M at YE2025) — the operating shell is thin; SG&A $9.9M/qtr (up from $1.1M) as it staffs an institutional platform. No debt. The liquidity story rests entirely on the staked-ETH being monetizable (it is, via liquid-staking wrappers).
• Market reaction: the stock is down ~95% from its post-announcement ATH ($124.12 high → mid-single-digits) and has been chopping in the ~$6–11 range through 2026. The print itself was a non-event vs. ETH's move — confirming the stock trades as an ETH-beta, not on operating results.

Unusual vs. own history: everything — a year ago this was a sub-$1M-revenue affiliate shell. The "earnings" are now a leveraged ETH mark.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts/ in research layer; tone read from the Q1 FY2026 call.

What management is focused on: "compound ETH per share over time," "maximize productivity with risk management top of mind," and beating the Ethereum staking rate as the explicit hurdle (Chalom). Capital-allocation philosophy is strikingly conservative for crypto: "We're not looking for VC-like returns … we're looking to hit singles and doubles," keeping the "vast majority in simple and liquid staking" with only a measured minority in higher-yield DeFi.

Tone shift over time: From euphoric (June 2025 launch, +400% pop, "largest ETH holder globally") → to defensive-but-disciplined through the late-2025/early-2026 drawdown. In Feb 2026 Lubin and Chalom explicitly "urged investors to look beyond recent price action" as prices plunged. The recurring phrases now: "institutional-grade," "ecosystem-aligned capitalism," "long-term capital advantage." The thing they stopped saying: bravado about out-accumulating BitMine ("game on") has cooled into yield-discipline language — a sentiment de-escalation that reads as maturity, not panic.

Lens 7 · Comps

• P/E, EV/EBIT, EV/Sales, dividend yield, 5-yr avg ROE: n/a — not meaningful / not sourced. A pre-cash-flow treasury vehicle with GAAP losses driven by crypto marks has no informative earnings multiple. Anyone quoting a P/E here is quoting noise.
• The real comp insight: SBET at 0.83x mNAV is cheaper than its own ETH and cheaper than a 1.0x ETF — the bull's entire valuation case. The risk: DAT discounts can persist or widen (the market is saying "we'd rather own ETH directly than trust the wrapper"). BMNR's scale (6x the ETH, ~3.4% of supply, Tom Lee targeting 5%) makes it the category's gravity well and SBET the perennial #2.

Lens 8 · Stock-Price Catalysts (last ~12 months — the company is only ~1yr old in this form)

Moves >5% and what they reveal:

• +400% (May/Jun 2025): the Consensys $425M PIPE + ETH-treasury pivot announcement — the defining event.
• +26% (Jul 8 2025): ETH treasury topping 200K ETH.
• −20% (2025): announcing the $6B ATM (i.e., the promise of massive dilution) — the market punished issuance capacity.
• −55% over six months / ~95% off ATH (H2 2025–Q1 2026): the ETH drawdown (ETH $4,829 Aug peak → October crash → ~$1,660) dragged the levered proxy down harder than spot.
• Russell 2000/3000 inclusion (eff. Jun 29 2026): opens ~$12T of passive capital; muted reaction on announcement (−0.8%) but a structural forward bid.
• Galaxy Onchain Yield Fund MOU (May 11 2026): reframed the yield story; modest positive.

Pattern the market actually reacts to: (1) ETH price, dominantly; (2) dilution signals (ATM size = down) vs. accretion signals (buyback, sub-NAV buying = up); (3) legitimacy markers (Russell, BlackRock-pedigree hire). It does not react to the legacy operating business at all. This is a pure ETH-plus-capital-allocation instrument.

---

Phase C — Judge people & books

Lens 9 · Management

The single strongest qualitative factor in the entire dossier.

1. Track record. Co-CEO Joseph Chalom spent 20 years at BlackRock, ending as MD/Head of Strategic Ecosystem Partnerships and interim Deputy COO / COO of BlackRock Solutions (Aladdin). He supervised the creation of IBIT, ETHA, and BUIDL — the largest BTC ETP, the largest ETH ETP (>$10B), and BlackRock's tokenized fund. For an ETH-treasury platform, you cannot hire a more credentialed operator. Chairman Joseph Lubin is an Ethereum co-founder and Consensys CEO — unparalleled protocol access. Founder/President Rob Phythian (legacy SharpLink CEO) stepped back to President.
2. Tenure & skin in the game. New leadership (since mid-2025). Consensys is the anchor holder via the $425M PIPE; institutional ownership rose from ~6% to ~46% across 2025 (+~60 new institutions in Q4 2025). Specific insider share-ownership percentages: n/a (would require the DEF 14A / Form 4s; not run this wave).
3. Capital-allocation history. Short but encouraging: when the stock fell below NAV they authorized a $1.5B buyback and bought (≈939K shares at $15.98 avg) rather than blindly issuing — textbook-correct for a sub-1.0x mNAV vehicle. ROE/ROIC are not meaningful yet (GAAP losses on marks).
4. Red flags. (a) Related-party adjacency: the Chairman's company (Consensys) is the lead investor and the L2 (Linea) where $200M is deployed — alignment is a double-edged sword. (b) Promotional lineage: the company itself is a meme-adjacent +400% pivot; the category attracts hype. (c) Tiny cash buffer ($16.9M) against a $9.9M/qtr SG&A run-rate means continued reliance on monetizing ETH or issuing equity.
5. Founder vs. professional manager. A hybrid: protocol-founder Chairman (Lubin) + institutional-operator Co-CEO (Chalom). For this stage (scaling an institutional treasury platform), that pairing is close to ideal — vision + Wall-Street operating rigor.

Lens 10 · Forensic Red Flags

Acting as a forensic analyst. The accounting is unusually clean in structure (it's mostly "hold an asset, mark it") but carries DAT-specific traps:

• Revenue recognition: staking rewards recognized as revenue ($11.5M) — straightforward, but the LsETH/weETH derivative accounting and a pending FASB fair-value decision mean the basis of measurement is in flux; the $191.7M impairment was taken at intraday lows on staking derivatives, which is conservative-but-volatile.
• Earnings vs. cash: the $685.6M "loss" is ~99% non-cash marks; conversely, the staking "revenue" is largely in-kind ETH, not cash — cash on hand fell to $16.9M. Watch the divergence between reported ETH-denominated yield and actual USD liquidity.
• Impairment asymmetry: under legacy crypto GAAP, marks down stick but recoveries don't reverse — so book value understates economic value in a recovery and the P&L is structurally lumpy/negative in drawdowns. Not a fraud flag; a measurement artifact to normalize out.
• Dilution / SBC: the $6B ATM is the biggest forensic watch-item — "Assumed Diluted Shares Outstanding" includes warrants, pre-funded warrants, options, RSUs; share count is the denominator that can quietly erode ETH-per-share if they issue at/below NAV. The buyback is the offset; net share-count trajectory is the number to track every quarter.
• Goodwill/intangibles, leases, contingencies: immaterial — this is an asset-holding shell, not an operating roll-up.

Regulatory findings (required).

• SEC Litigation Releases / AAERs: None. regulatory/regulatory-findings.md (EDGAR EFTS, LR + AAER, period 2021-06-17→2026-06-17) returned 0 findings.
• Non-SEC enforcement: web search for "SharpLink Gaming" (FTC OR DOJ OR FDA OR CFPB OR consent decree OR settlement OR fine OR penalty) surfaced no material enforcement actions as of Jun 2026. (Standard shareholder-bar trawling around a +400%/−95% stock is plausible but none material surfaced.)
• 10-K Item 3 (Legal Proceedings): not pulled this wave (filings not ingested per wave constraint) — open item, label n/a — filing not ingested.
• Net: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER) and web search as of 2026-06-17; 10-K Item 3 not independently reviewed this wave.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

(Per the unattended-loop rule, no forecast.ts create is logged.) For a DAT, projecting EPS is the wrong exercise — GAAP "EPS" is just a levered ETH mark. The right projection is NAV-per-share and mNAV, built bottom-up. All ``, arithmetic shown; ETH price is the master variable.

Inputs (anchored to latest ``): ~868K ETH; avg cost ~$3,609; ~192M shares out (Oct 2025); net cash ~$17M, no debt; staking yield ~3–4% net (compounds the ETH count ~3–4%/yr); SG&A ~$40M/yr run-rate; $1.5B buyback authorized; $6B ATM available.

NAV-per-share scenarios (FY ahead), ``:

• Inputs: NAV ≈ (ETH count × ETH price) + cash − negligible liabilities, ÷ diluted shares (~192M, before buyback/ATM effects).
• Bear (ETH $1,200): NAV ≈ 868K × $1,200 = $1.04B → ~$5.4/sh NAV. At a persistent 0.83x discount, price ≈ $4.5.
• Base (ETH ~$2,500): NAV ≈ 868K × $2,500 = $2.17B → ~$11.3/sh NAV. Discount narrows toward 0.9x on buyback/Russell flows → price ≈ $10.2.
• Bull (ETH $4,800, retest of 2025 high): NAV ≈ 868K × $4,800 = $4.17B → ~$21.7/sh NAV. Sentiment flips to a small premium (1.1x) on accretive issuance restarting → price ≈ $23.9.
• Yield kicker: staking adds ~3–4%/yr to the ETH count → ~+3–4% NAV/yr independent of price; buybacks below NAV add a few % to NAV/share. Net: SBET should out-compound spot ETH per-share over time if it disciplines issuance — the core long thesis.

The forecast that actually matters (would log if committed): "SBET mNAV ≥ 1.0x within 12 months" — i.e., does the discount close? p ≈ 0.35 — discounts in DAT-land have been sticky; closing it needs either an ETH bull market that reignites premium appetite or aggressive buyback execution. Not logged (breadth loop).

Lens 12 · Bull vs Bear

Bull case. SBET is the highest-quality, cheapest large-cap pure-play on Ethereum's institutionalization, run by the people who built BlackRock's crypto ETPs and co-founded the protocol. You buy ~868K staked ETH for 83 cents on the dollar, get ~3–4% yield compounding the ETH count, a $1.5B buyback mechanically accreting ETH-per-share while the discount persists, Russell inclusion (Jun 29) adding a structural passive bid, and optionality on a FASB fair-value fix that ends the cosmetic GAAP losses. If ETH re-rates and DAT-premium appetite returns, you get ETH beta + discount-closing + yield — a triple. The contrarian read: the market has thrown the levered proxy out with the bathwater, pricing it below the asset it holds despite best-in-class governance.

Bear case (permanent-impairment risks). (1) The DAT premium is structurally dead — once spot ETH ETFs exist (ETHA, >$10B, ~1.0x, lower fee, no dilution), the raison d'être of an equity wrapper evaporates; a 0.83x discount may be the new fair value, not a mispricing, and could widen. (2) Dilution overhang — a $6B ATM hangs over the stock; if management ever issues below NAV (or the market fears they will), ETH-per-share erodes and the discount deepens — the exact thing that sank confidence in the BMNR comparison. (3) It's a 1.0+ beta on a volatile asset with no operating cushion — $16.9M cash, $40M/yr SG&A; a sustained ETH bear forces ETH monetization at the worst time. Pre-mortem (18 months out, thesis broke): ETH chopped sideways at $1,500–2,000, the discount stuck at 0.8x, the buyback ran out of dry powder, BitMine's scale captured all the institutional ETH-DAT mindshare and index weight, and SBET drifted to a permanent ~0.75x "stale wrapper" multiple — dead money even as the ETH it holds was fine. Are multiples too high? No — at 0.83x mNAV the equity is cheap; the risk is the discount, not the multiple. Contrarian view the market refuses to see: that disciplined DATs (buy-below-NAV, never dilute-below-NAV) are structurally different from dilution-machine DATs, and SBET's governance earns a tighter discount than the category — the market is mispricing operator quality.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case.

• What structurally breaks the model: the equity wrapper is redundant. A spot ETH ETF gives the same exposure at ~1.0x with lower fees and zero dilution risk. SBET's only justifications are (a) issue-above-NAV accretion — impossible while it trades at 0.83x — and (b) excess yield, which is a few hundred bps that doesn't justify the equity-layer risk. The flywheel is mathematically off: below NAV you can't grow ETH/share by issuing, so growth depends on buybacks funded by… selling the very ETH you're hoarding, or more dilution. It's a snake eating its tail.
• Concentration: revenue is ~95% one line (staking) on one asset (ETH). If ETH staking yield compresses (more validators, protocol changes) or ETH underperforms BTC, the whole thesis sags.
• The moat is weaker than bulls think: "great management" doesn't create a moat when the product is a commodity (ETH) you can buy yourself. Lubin/Chalom lower the cost of capital, but they can't manufacture a premium the ETF era has structurally erased.
• Most dangerous competitor bulls underestimate: not BitMine — the ETHA ETF itself, which is the reason the premium died and the discount may be permanent.
• Worst capital-allocation / governance risks: the $6B ATM is a loaded gun pointed at ETH-per-share; the Consensys/Linea related-party web (Chairman's firm is lead investor and the L2 hosting $200M and a key validator-ecosystem player) is a conflict that could prioritize protocol-promotion over shareholder return.
• What must hold for today's price: that ETH doesn't enter a multi-year bear, that the discount doesn't widen past ~0.8x, and that management never issues below NAV. If growth/ETH disappoints 20–30%: NAV-per-share falls ~20–30% and the discount likely widens (negative reflexivity) — a 40–50% equity drawdown from a 25% ETH drop. Single permanent-impairment scenario: a major slashing/smart-contract/DeFi exploit on its staked/restaked/DeFi-deployed ETH (it has $200M on Linea + a $125M DeFi fund) that forces a real, realized loss of principal — plausibility: low-but-nonzero, and explicitly hand-waved by management as "human exploits."

Lens 14 · Management Questions (ordered by information value)

1. At today's ~0.83x mNAV, what is your hard rule for issuing equity under the $6B ATM — will you commit publicly to never issuing below NAV?
2. How much buyback dry powder is actually deployable without selling staked ETH, given $16.9M cash — and would you sell ETH to fund buybacks if the discount persists?
3. What discount-to-NAV level triggers aggressive buyback, and how do you weigh buyback vs. accumulation when both can't be funded?
4. Why should an investor own SBET instead of the ETHA ETF — quantify the per-share value you add net of dilution and SG&A?
5. What is your honest base case for how long the NAV discount persists, and what specifically closes it?
6. How do you manage related-party risk given Consensys is lead investor, Linea hosts $200M, and the Chairman runs Consensys?
7. What is the net staking yield after all fees/slashing reserves, and what's your edge in "beating the staking rate" sustainably?
8. What is your slashing / smart-contract / DeFi-exploit loss tolerance, and have you ever taken a realized principal loss?
9. How do you think about BitMine's scale advantage (6x your ETH, ~3.4% of supply) — does the #2 position have a structural disadvantage on index weight and mindshare?
10. What does the legacy affiliate business contribute, and will you divest it to simplify the story?
11. What's the plan if the FASB fair-value decision goes against you and the GAAP-loss optics persist?
12. What are the terms and fee economics of the Galaxy Onchain Yield Fund, and why give up 20% of the capital to Galaxy?
13. At what ETH price does your liquidity (cash + monetizable ETH) get tight relative to SG&A and buyback commitments?
14. What governance/lock-up applies to Consensys's stake, and is there overhang risk if they exit?
15. Three years out, what's the single metric you want to be judged on — and what's the target?

---